Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.720
-0.020 (-1.15%)
At close: Dec 26, 2025, 4:00 PM EST
1.690
-0.030 (-1.74%)
After-hours: Dec 26, 2025, 4:36 PM EST
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $78.87 million as of December 26, 2025. Its market cap has decreased by -6.49% in one year.
Market Cap
78.87M
Enterprise Value
70.51M
1-Year Change
-6.49%
Ranking
Category
Stock Price
$1.72
Market Cap Chart
Since June 28, 2018, Entera Bio's market cap has increased from $71.77M to $78.87M, an increase of 9.90%. That is a compound annual growth rate of 1.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 78.87M | 1.01% |
| Dec 31, 2024 | 78.08M | 351.66% |
| Dec 29, 2023 | 17.29M | -17.80% |
| Dec 30, 2022 | 21.03M | -74.04% |
| Dec 31, 2021 | 81.03M | 308.59% |
| Dec 31, 2020 | 19.83M | -23.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.01B |
| Johnson & Johnson | 496.36B |
| AbbVie | 406.29B |
| UnitedHealth Group | 295.80B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 263.96B |
| Novo Nordisk | 232.28B |